id
int64 0
34.5k
| question
stringlengths 7
1.83k
| choice0
stringlengths 1
1k
| choice1
stringlengths 1
984
| choice2
stringlengths 1
1.82k
| choice3
stringlengths 1
1.82k
| choice4
stringlengths 1
1.94k
| label
int64 0
4
| task
stringclasses 3
values |
|---|---|---|---|---|---|---|---|---|
8,843 |
Lipoyl-[acp]をを化学式で書くと?
|
C26H29O16
|
C16H23NO8
|
C8H13OS3R
|
C28H48O5
|
C15H24
| 2 |
formula
|
15,949 |
C20H12Oの別表現は?
|
Hydrocinnamyl acetate
|
6-Hydroxybenzo[a]pyrene
|
PGA1-GS
|
7-Angelyl-9-(-)-viridiflorylretronecine
|
4-o-Galloylbergenin
| 1 |
replace
|
12,654 |
C17H13ClN2O4の別の言い方は?
|
メスアキサントンB
|
Dithiazanine iodide
|
キザロホップ
|
3-ニトロトルエン
|
Falcarindiol
| 2 |
replace
|
5,191 |
1-Methyl-6-(1,2,3,4-tetrahydro-6-hydroxy-2-naphthyl)-2(1H)-pyridoneをを分子式で表すと?
|
C19H22O8
|
C16H17NO2
|
C24H22O14
|
C29H48N7O17P3S
|
C26H34O11
| 1 |
formula
|
12,058 |
C14H9NO3の異なる表現は?
|
クリナシアジン
|
ハロキシホップメチル
|
キュラシンA
|
o-アニシジン
|
Oleandomycin 2'-O-phosphate
| 0 |
replace
|
25,745 |
C5H12N2O2は別の呼び方では?
|
Guaiacyl lignin
|
Short-chain trans-2,3-dehydroacyl-CoA
|
UDP-galactose
|
2,22-Dideoxyecdysone
|
2,5-Diaminopentanoate
| 4 |
replace
|
13,879 |
Pixuvri (TN)の別表現は?
|
Dillar (TN)
|
Magnesium phosphate pentahydrate
|
Pixantrone dimaleate (USAN)
|
Avelumab (genetical recombination) (JAN)
|
Ammonia water (TN)
| 2 |
replace
|
24,724 |
PACAP-27を言い換えると?
|
Thiophos
|
Neurokinin B
|
2,3,9,10-Tetrahydroxyberberine
|
II2Xylbeta-Ml4Cer
|
Pituitary adenylate cyclase-activating peptide-27
| 4 |
replace
|
2,702 |
Korupensamine Aをを化学式で記述すると?
|
C42H72O13
|
C23H25NO4
|
C81H134NO26P2(C24H41O21)n
|
C43H70N10O27P2
|
C22H28N2O2
| 1 |
formula
|
8,714 |
プロピオン酸テストステロンの別記述は?
|
Spectinomycin hydrochloride hydrate (JP18)
|
Diamorphine (BAN)
|
ブロクスウリジン (JAN)
|
Teriparatide acetate (JAN)
|
テストステロンプロピオン酸エステル (JP18)
| 4 |
replace
|
27,413 |
Marfan syndrome SUBGROUP Marfan lipodystrophy syndromeを言い換えると?
|
肺動脈性肺高血圧症
|
マルファン症候群 下位グループ マルファン・リポジストロフィ症候群
|
原発性高シュウ酸尿症
|
顔面中部低形成・難聴・楕円赤血球症および腎石灰化症
|
T-B+ 重症複合免疫不全症 上位グループ 獲得免疫の障害 原発性免疫不全症
| 1 |
replace
|
12,881 |
C6H10O6の異なる名称は?
|
(R)-Chiral alcohol
|
Bis-(3',5')-cyclic diGMP
|
3'-Hydroxy-terminated oligonucleotide
|
2,4-Dihydroxy-6-methylbenzoic acid
|
myo-Inosose-5
| 4 |
replace
|
2,842 |
5'-ヒドロキシストレプトマイシンの異なる表現は?
|
Sulfuric monoester
|
5'-Hydroxystreptomycin
|
17beta-Hydroxy-5alpha-androst-2-ene
|
Isopimpinellin
|
Stovaine
| 1 |
replace
|
27,863 |
エピソード性発熱と免疫調節不全を伴う自己炎症の別呼称は?
|
Bifid nose with or without anorectal and renal anomalies
|
Xanthomatosis SUBGROUP Cerebrotendinous xanthomatosis
|
Autosomal dominant slowed nerve conduction velocity
|
Louis-Bar syndrome
|
Autoinflammation with episodic fever and immune dysregulation
| 4 |
replace
|
20,491 |
Linrodostat (USAN/INN)をの組成式は?
|
C5H8O2
|
C16H26N5O8. Gd
|
C24H24ClFN2O
|
((C9H9NO2)w(C9H9NO)x(C6H12N2O)y(C3H5NO)z)n. (C2H4O2)nx
|
CH2O
| 2 |
formula
|
19,106 |
メフェナム酸をを分子式で書くと?
|
C39H70N7O17P3S
|
C15H28O7P2
|
C15H15NO2
|
C12H19O2PS3
|
C7H8O5
| 2 |
formula
|
32,698 |
CH3ORは別の呼び方では?
|
Cyanidin 3-O-sophoroside
|
5-Deoxystrigol
|
Long-chain alcohol
|
Carbam
|
16beta-Methyl-D-homo-17a-oxa-5alpha-androstane-3,17-dione
| 2 |
replace
|
8,243 |
Citraconic acid, dimethyl esterの別名は?
|
Ribonucleoside 5'-triphosphate
|
Mefenamic acid
|
Formyl phosphate
|
Semicarbazide hydrochloride
|
Methylmaleic acid, dimethyl ester
| 4 |
replace
|
32,214 |
モルヒネ塩酸塩(テルモ)の別記述は?
|
Morphine hydrochloride trihydrate
|
Meteneprost (USAN/INN)
|
Pyrimethamine (JAN/USP/INN)
|
Safinamide methanesulfonate
|
Albumin human (USP)
| 0 |
replace
|
2,326 |
Tolylfluanidをの組成式は?
|
C18H22NO
|
C20H32O2
|
C10H13Cl2FN2O2S2
|
C27H50NO8PR
|
C20H34O4
| 2 |
formula
|
31,372 |
C20H34O5を言い換えると?
|
Maobushisaishinto
|
Olorinab (USAN/INN)
|
Millact (TN)
|
Prosmon (TN)
|
Iodine zinc iodide for Kantop (TN)
| 3 |
replace
|
13,274 |
)を使用した商品は?
|
FROVATRIPTANSUCCINATE(EndoUSA)
|
GANIRELIXACETATE(LupinPharmaceuticals)
|
FIRMAGON(FerringPharmaceuticals)
|
ERYTHROMYCIN(REMEDYREPACK)
|
LAMOTRIGINE(NCSHealthCareofKY)
| 4 |
product
|
28,439 |
Clotrimazole and betamethasoneの別呼称は?
|
Norethisterone (JP18)
|
Foslevodopa and foscarbidopa
|
ショウハンゲカブクリョウトウ
|
ジオキシベンゾン
|
クロトリマゾール・ベタメタゾン
| 4 |
replace
|
28,732 |
Mannosylfructoseの異なる名称は?
|
ニコランジル
|
Thiosulfuric acid
|
Diacylglyceryl-N,N,N-trimethylhomoserine
|
トレハロース
|
beta-D-Fructofuranosyl-alpha-D-mannopyranoside
| 4 |
replace
|
1,950 |
C23H32N2O2Sの別の言い方は?
|
Lidaprim (TN)
|
Tiocarlide (INN)
|
Hainosankyuto
|
Oremepermin alfa (genetical recombination) (JAN)
|
Vyalev (TN)
| 1 |
replace
|
19,559 |
Yttrium Y 90 labetuzumab (USAN)の異なる名称は?
|
Adavosertib (USAN)
|
CES-Cide (TN)
|
alpha-Naphthylacetic acid
|
Cellulose sodium phosphate (USP)
|
Imidoline hydrochloride (USAN)
| 1 |
replace
|
5,439 |
レボモラミドの異なる表記は?
|
Levomoramide (INN)
|
Rubella virus vaccine live (USP)
|
Ac-Di-Sol (TN)
|
Lecimibide (USAN)
|
Alpiniae fructus (TN)
| 0 |
replace
|
7,316 |
C6H11N2O4PS3の異なる表記は?
|
上皮小体ホルモン
|
メチダチオン
|
Cryptolepine
|
(1aalpha,2beta,3alpha,11calpha)-1a,2,3,11c-Tetrahydro-6,11-dimethylbenzo[6,7]phenanthro[3,4-b]oxirene-2,3-diol
|
カピラリシン
| 1 |
replace
|
29,559 |
Navenone Bをは分子式で表すと?
|
C23H28O10
|
C18H16O7
|
C16H16O
|
C176H277N57O55S7
|
C15H19N3O2
| 2 |
formula
|
12,824 |
C17H12Cl2N2Oを言い換えると?
|
MAGE-3 (271 - 279)
|
Benzidine
|
Arg-OEt
|
クロルピクリン
|
フェナリモール
| 4 |
replace
|
29,143 |
Methyl [5-(phenylsulfanyl)-1H-benzimidazol-2-yl]carbamateをは化学構造で表すと?
|
C19H17ClN4
|
C21H30O2
|
CNR
|
C10H17O10PR2(C5H8O6PR)n
|
C15H13N3O2S
| 4 |
formula
|
31,377 |
プレミトラマイシンA3'をは分子式で表すと?
|
C5H10N2O2
|
C14H10N2O4
|
C40H50O18
|
C17H28N2O14P2
|
C12H10
| 2 |
formula
|
11,961 |
Medicarpinの別の呼び方は?
|
L-2,5-Dihydrophenylalanine
|
DDA
|
(-)-Medicarpin
|
Flavanone
|
Specionin
| 2 |
replace
|
21,314 |
Tetrachlorocatecholをを組成式で記述すると?
|
C4H6N2O3R2
|
C16H22N2O14P2
|
C6H2Cl4O2
|
C25H33NO2
|
C12H9NO2
| 2 |
formula
|
23,256 |
C22H32O2の別名称は?
|
1,2-Dimethylhydrazine
|
Sodium equilin sulfate
|
ボリシチン
|
16beta-Methylpregn-4-ene-3,20-dione
|
alpha-Maltose 1-phosphate
| 3 |
replace
|
32,206 |
Capillartemisin Aをを組成式で書くと?
|
C20H28N2O4
|
C12H14O2
|
C15H10O10S
|
C16H18O5
|
C19H24O4
| 4 |
formula
|
28,507 |
C6H12O5の別の言い方は?
|
17beta-Hydroxy-4,4,17-trimethylandrost-5-en-3-one
|
beta-L-Rhamnose
|
1-Amino-4-chlorobenzene
|
Hydrazoate
|
2-Amino-2-deoxyisochorismate
| 1 |
replace
|
1,972 |
C19H17Cl3N2S. HNO3の異なる名称は?
|
テナリジン
|
Litifilimab (USAN)
|
エンビオマイシン
|
Butoconazole nitrate (USP)
|
Prorenoate potassium (USAN/INN)
| 3 |
replace
|
25,274 |
Adenosine 5'-phosphosulfateをを化学式で表すと?
|
C6H15N3S
|
C12H8Cl2O
|
C16H23N6O11PS(C5H8O6PR)n(C5H8O6PR)n
|
C10H14N5O10PS
|
C5H11NO
| 3 |
formula
|
7,569 |
Sucroferric oxyhydroxideの別記述は?
|
Iron sucrose (USP)
|
イットリウム(Y90)ラベツズマブ
|
Ambazone (INN)
|
Sinapultide (USAN/INN)
|
メシル酸ゾニポリド
| 0 |
replace
|
2,273 |
TASIMELTEON(TevaPharmaceuticals)を材料とする医薬品は?
|
GENERICTASIMELTEON(AmnealPharmaceuticalsNYLLC)
|
DEPAKOTE(AbbVie)
|
ANTICOAGULANTCITRATEDEXTROSEAACD-A(ArteriocyteMedicalSystems)
|
AMOXICILLIN(NuCarePharmaceutials)
|
GLYCOPYRROLATE(NivagenPharmaceuticals)
| 0 |
product
|
8,454 |
デクスメチルフェニデートの異なる表記は?
|
Anileridine (USP/INN)
|
Phthalylsulfathiazole (INN)
|
Dexmethylphenidate (INN)
|
Icopezil maleate (USAN)
|
Nifuratrone (USAN/INN)
| 2 |
replace
|
7,801 |
C15H24O5の別表現は?
|
Vinbarbital (INN)
|
Ibezapolstat (USAN)
|
Tolimidone (USAN)
|
Artenimol (USAN/INN)
|
Senshibyakujutsusan
| 3 |
replace
|
21,680 |
Phenelzineをの化学構造は?
|
C6H11NO4
|
C6H4N2
|
C8H12N2
|
C17H20O2
|
C6H10N3O4R(C2H2NOR)n
| 2 |
formula
|
29,129 |
Altretamine (USP/INN)の別名は?
|
Lorcainide (INN)
|
Hexalen (TN)
|
Sinefungin (USAN/INN)
|
Paraldehyde (USP)
|
Frovatriptan (INN)
| 1 |
replace
|
6,378 |
Pentetrazol (INN)の別呼称は?
|
Pentylenetetrazol
|
Linaclotide acetate (USAN)
|
トウキシャクヤクサンカニンジン
|
Ceftobiprole (USAN/INN)
|
Ilofotase alfa (USAN/INN)
| 0 |
replace
|
31,665 |
Leadは別の呼び方では?
|
N-Acetyl-beta-D-galactosaminyl-1,4-beta-D-glucuronyl-N-acetyl-1,3-beta-D-galactosaminylproteoglycan
|
フェニルプロピオン酸ナンドロロン
|
Neurophysin II
|
2,3-Dihydroxycyclopentaneundecanoic acid
|
鉛
| 4 |
replace
|
21,023 |
アタパルガイトの別記述は?
|
Trifluperidol (USAN/INN)
|
Attapulgite (DCF)
|
Mucotec (TN)
|
Balsalazide (INN)
|
Lutetium (177Lu) chloride
| 1 |
replace
|
13,508 |
Naproxcinod (USAN/INN)をの分子式は?
|
C39H32ClF10N7O5S2
|
C18H21NO6
|
C6H12N4
|
C19H23NO3. HCl
|
C24H31FO6
| 1 |
formula
|
26,763 |
ペマジール(インサイト・バイオサイエンシズ・ジャパン)の異なる名称は?
|
Leriglitazone hydrochloride (USAN)
|
Chemet (TN)
|
Akineton (TN)
|
Pemazyre (TN)
|
Sulfonterol hydrochloride (USAN)
| 3 |
replace
|
16,796 |
D-Abequosyl-D-mannosyl-rhamnosyl-D-galactose-1-diphospholipidの異なる表現は?
|
D-Mannose 1,6-bisphosphate
|
alpha-D-Abequosyl-(1->3)-alpha-D-mannosyl-(1->4)-alpha-L-rhamnosyl-(1->3)-alpha-D-galactosyl-diphosphoundecaprenol
|
Iron cyanide (Fe(CN)3)
|
Adenylated molybdopterin
|
Latrunculin A
| 1 |
replace
|
31,737 |
C10H14N5O9Pの異なる表現は?
|
(-)-Medicarpin
|
NAc-AAA-ME
|
8-Oxo-GMP
|
6,8a-Seco-6,8a-deoxy-5-oxoavermectin ''1a'' aglycone
|
(R)-Methylmalonyl-CoA
| 2 |
replace
|
28,927 |
C20H34Oの異なる表記は?
|
9,10,18-Trihydroxyoctadecanoic acid
|
alpha,beta-Dihydroxyethyl-TPP
|
Kuwanone G
|
Cyclooctat-9-en-7-ol
|
7-(2-Hydroxy-3-amino-3-carboxypropyl)wyosine in tRNA(Phe)
| 3 |
replace
|
5,904 |
Amicoumacin A 2-phosphateをを組成式で書くと?
|
C8H5F3N2OS
|
C13H7Cl2F3N2O4S
|
C18H35N3O12
|
(C26H36O24)n
|
C20H30N3O10P
| 4 |
formula
|
12,631 |
水酸化ナトリウム(小堺製薬)は別の呼び方では?
|
Sasapyrine (JAN)
|
マリマスタット
|
水酸化ナトリウム (JP18)
|
リナボンキバルト
|
トロンボモデュリン アルファ (遺伝子組換え) (JAN)
| 2 |
replace
|
18,687 |
NDP-1-epi-valienol 7-phosphateをは組成式で表すと?
|
C15H20O3
|
C16H23N5O17P2
|
C12H22O17P3R
|
C7H11NO3
|
C21H41N5O11
| 2 |
formula
|
19,910 |
8-Oxoguanineをを化学構造で表すと?
|
C66H83N17O13
|
C27H44O16
|
C32H40O19
|
C5H5N5O2
|
C22H24N2O8
| 3 |
formula
|
16,772 |
ゴカヒの別の言い方は?
|
グロフィタマブ
|
Ibipinabant (USAN/INN)
|
石菖根
|
南五加皮
|
Demiditraz (USAN/INN)
| 3 |
replace
|
14,122 |
Elfucose (USAN)をを分子式で表すと?
|
C18H22O2
|
C18H22N8O2S
|
C24H36N8O10P2S2
|
C6H12O5
|
C19H22N2O
| 3 |
formula
|
8,691 |
エナメル質形成不全症 下位グループ 長胴歯を伴うエナメル質形成不全・未成熟 の別呼称は?
|
Arrhythmogenic cardiomyopathy with variable ectodermal abnormalities
|
Early-onset vitamin B6-dependent epilepsy SUPERGRP Early-onset epilepsy
|
Amelogenesis imperfecta SUBGROUP Amelogenesis imperfecta hypoplastic-hypomaturation with taurodontism
|
Primary peritoneal carcinoma
|
Snijders Blok-Fisher syndrome
| 2 |
replace
|
33,032 |
Glyhexamide (USAN/INN)をは化学式で表すと?
|
C8H11N3O4
|
C18H17Cl2FN4OS
|
C23H25N9O
|
C16H22N2O3S
|
C2066H3194N550O673S12
| 3 |
formula
|
23,686 |
3,6-Dihydronicotinic acidをを化学構造で記述すると?
|
C20H34NO16R
|
Ca3(AsO4)2
|
C6H15O5PS2
|
C6H7NO2
|
C5H4N5R
| 3 |
formula
|
25,637 |
Cinerin Iの別表現は?
|
N,N-Dimethylglycine
|
Cetraxate
|
シネリンI
|
スピロルシジン
|
1-Amino-1-deoxy-scyllo-inositol 4-phosphate
| 2 |
replace
|
22,395 |
C6H6N2O3の別名称は?
|
Trimethylenetetraurea
|
4-Amino-2-nitrophenol
|
テフルベンズロン
|
トリメチルアミン-N-オキシド
|
Ozagrel hydrochloride
| 1 |
replace
|
19,980 |
C29H30F3N2O5Pの別呼称は?
|
Enduron (TN)
|
Fosdagrocorat (USAN/INN)
|
Paromomycin (TN)
|
Salvia miltiorrhiza root (JP18)
|
Golvatinib (USAN)
| 1 |
replace
|
11,363 |
C8H14NO6Rの別表現は?
|
Methyl5-(but-3-en-1-yl)amino-1,3,4-oxadiazole-2-carboxylate
|
N-Acetyl-beta-D-hexosaminide
|
alpha-D-Galactosyl-1,3-beta-D-galactosyl-1,4-N-acetyl-D-glucosamine
|
[Xanthine oxidase]
|
Oxalic acid
| 1 |
replace
|
16,868 |
C25H31NO. HClの別の言い方は?
|
Cefotetan (JP18/USP/INN)
|
ヒストプラスミン
|
テイレキシ
|
Butaclamol hydrochloride (USAN)
|
Etoxadrol hydrochloride (USAN)
| 3 |
replace
|
16,628 |
Cubebolをの化学構造は?
|
C10H16O2
|
C27H36O
|
C23H26O3
|
C31H23BrO2S
|
C15H26O
| 4 |
formula
|
27,998 |
硝子体網膜変性 下位グループ スティックラー症候群 Snowflake 硝子体網膜変性 (SVD) Wagner 症候群 (WGN) Knobloch 症候群 (KNO) S 錐体増強症候群 (ESCS) 常染色体優性硝子体網脈絡膜症 (VRCP) の別名は?
|
Catel-Manzke syndrome
|
Vitreoretinal degeneration SUBGROUP Stickler syndrome (STL) Snowflake vitreoretinal degeneration (SVD) Wagner syndrome (WGVRP) Knobloch syndrome (KNO) Enhanced S-cone syndrome (ESCS) Autosomal dominant vitreoretinochoroidopathy (VRCP)
|
Occult macular dystrophy SUPERGRP Macular dystrophy
|
Brazilian purpuric fever
|
B virus infection
| 1 |
replace
|
30,375 |
1,3-Dimethyl-8-isoquinolinolをの化学構造は?
|
C2H3NO3(CH2)n
|
C18H26NO3. Br
|
C15H8O4
|
C11H11NO
|
C15H12O3
| 3 |
formula
|
29,643 |
尋常性座瘡の別名称は?
|
にきび 上位グループ 嫌気性菌感染症
|
猩紅熱 上位グループ レンサ球菌感染症
|
先天性無爪 上位グループ 非症候性先天性爪疾患
|
乳児期発症パーキンソニズム・ジストニア
|
膵リパーゼ欠損症
| 0 |
replace
|
25,264 |
C30H32Cl3N3O4. HClの別名は?
|
Valategrast hydrochloride (USAN)
|
エルタペネム
|
ソホスブビル (JAN)
|
Cyanocobalamin (60Co) (INN)
|
カソピタントメシル酸塩
| 0 |
replace
|
18,189 |
Chamissoninをを化学構造で記述すると?
|
C17H27N3O23P2S2
|
C16H14O6
|
C8H6O
|
C45H68N7O18P3S
|
C15H20O4
| 4 |
formula
|
33,475 |
C6H7NOは別の呼び方では?
|
Nicotinyl alcohol (USAN)
|
Shojokito
|
Kasal (USAN)
|
Acetylaminonitropropoxybenzene
|
Acetyldigoxin
| 0 |
replace
|
23,601 |
C12H20N2O3の異なる名称は?
|
Ipconazole
|
Cholinephosphorylneogalatriaosylceramide
|
5-Hydroxymethylfurfuryl alcohol
|
Pirbuterol
|
(S,S)-Butane-2,3-diol
| 3 |
replace
|
31,431 |
プロスタグランジンD3の異なる表記は?
|
Oestradiol mustard
|
Prostaglandin D3
|
Beiwutine
|
Phenothrin
|
Dihydroeuparin
| 1 |
replace
|
22,173 |
C16H18N6Oの異なる表記は?
|
Temtokibart (USAN/INN)
|
Tifluadom (INN)
|
Ceruletide (USAN/INN)
|
Anzupgo (TN)
|
Darunavir and cobicistat
| 3 |
replace
|
24,311 |
ジャマイカミドの別名は?
|
Jamaicamide
|
5'-Methoxy-O-desmethylangolensin
|
Bruceine D
|
L-Glutamyl-[pcp]
|
2-Acyl-sn-glycerol 3-phosphate
| 0 |
replace
|
5,055 |
メダゼパム (JP18)を言い換えると?
|
Nezastomig (USAN)
|
Medazepam (JP18/INN)
|
Fluciclovine (18F) (INN)
|
Tiamenidine hydrochloride (USAN)
|
シベプレンリマブ (遺伝子組換え) (JAN)
| 1 |
replace
|
14,862 |
di-trans,poly-cis-Octaprenyl diphosphateをは分子式で表すと?
|
C6H5ClO2
|
C18H18O2
|
C12H15N3O2S
|
C14H18N2O
|
C40H68O7P2
| 4 |
formula
|
27,897 |
H. pylori KDO2-lipid A 1-(2-aminoethyl phosphate)の別表現は?
|
Quinolin-2-ol
|
(Indol-3-yl)acetyl-L-aspartate
|
1-PEtN-KDO2-lipid A
|
Oxidized dithiothreitol
|
22alpha-Hydroxy-campesterol
| 2 |
replace
|
32,802 |
シテイトウの異なる表現は?
|
Pivekimab (USAN)
|
アロガバット
|
柿蒂湯
|
Sembragiline (USAN/INN)
|
Etozolin (USAN/INN)
| 2 |
replace
|
26,790 |
Nirmatrelvir and ritonavirを材料とする薬品名は?
|
パキロビッド(ファイザー)
|
サンザシ(栃本天海堂)
|
トウドクカツ(高砂薬業)
|
アルピニー(久光製薬)
|
親水クリーム(東豊薬品)
| 0 |
product
|
10,314 |
ニンドウ(ツムラ)を主とした商品は?
|
ニンドウ(ウチダ和漢薬)
|
アクラシノン(日本マイクロバイオファーマ)
|
グラニセトロン(メディサ新薬)
|
オゼックス(富士フイルム富山化学)
|
PODOFILOX(PadagisUSLLC)
| 0 |
product
|
4,810 |
Dethiobiotinの別表現は?
|
1,2,3,6,7,8-Hexachlorodibenzodioxin
|
Dialkyl ketone
|
デスチオビオチン
|
beta-ホカエコール酸
|
Guanosine 3'-diphosphate 5'-triphosphate
| 2 |
replace
|
17,310 |
L-Methionyl-tRNAの別表現は?
|
N4-Aminopropylspermidine
|
(+)-Pimaric acid
|
L-Methionyl-tRNA(Met)
|
Xylan
|
1,5-Diaminopentane
| 2 |
replace
|
5,508 |
C6H9O3R3(C2H4O)w(C2H4O)z(C2H4O)y(C2H4O)xの別表現は?
|
オキセトロン
|
シチオアート
|
ベンプロペリンリン酸塩 (JAN)
|
Polysorbate 65 (NF)
|
Quifenadine (INN)
| 3 |
replace
|
14,530 |
ローヘパ(エイワイファーマ)を主材料とする商品名は?
|
パルナパリンNa(扶桑薬品工業)
|
カンキョウ(高砂薬業)
|
TRAMADOLHYDROCHLORIDE(AsclemedUSA)
|
RINGERS(BaxterHealthcareCorporation)
|
クロトリマゾール(岩城製薬)
| 0 |
product
|
27,997 |
小柴胡湯(三和生薬)を材料とする医薬品名は?
|
DOCETAXEL(IngenusPharmaceuticals)
|
コンコエイト(日本血液製剤機構)
|
グリセリン(ムネ製薬)
|
小柴胡湯(大峰堂薬品工業)
|
ATP(コーアイセイ)
| 3 |
product
|
13,348 |
Galloway-Mowat syndromeの別名は?
|
腸管毒素原性大腸菌感染症
|
Hao-Fountain 症候群
|
後天性赤芽球癆
|
Dworschak-Punetha 神経発達症候群
|
ギャロウェイ・モワト症候群
| 4 |
replace
|
17,314 |
Thioacetamideをは化学構造で表すと?
|
C16H24N2O15P2
|
C2H5NS
|
C8H8O3
|
C4H10O4S
|
C20H28O12
| 1 |
formula
|
32,520 |
Trimoxamine hydrochloride (USAN)をを分子式で書くと?
|
C6472H9946N1714O2024S44
|
C6455H9955N1721O2039S47
|
C17H19N3. C4H4O4
|
C15H23NO3. HCl
|
C3H11NO7P2
| 3 |
formula
|
5,855 |
Ethyl 2-hydroxy-2,2-bis(4-chlorophenyl)acetateの別名称は?
|
UDP-3-O-(beta-hydroxymyristoyl)-N-acetylglucosamine
|
Vitamin K hydroquinone
|
Chlorobenzilate
|
OCDD
|
Lirioresinol-B dimethyl ether
| 2 |
replace
|
6,825 |
Flavodilol maleate (USAN)の異なる表現は?
|
マレイン酸フラボジロール
|
Zanamivir (USP/INN)
|
Trandolapril (JAN/USP/INN)
|
Mannosulfan (INN)
|
Chlorprothixene hydrochloride (JAN)
| 0 |
replace
|
32,522 |
C12H19NOを言い換えると?
|
6-Diazo-5-oxo-L-norleucine
|
2'-Deoxyguanosine 5'-monophosphate
|
(2E,5S,6E,8E,10E)-1-Aminododeca-2,6,8,10-tetraen-5-ol
|
Inorganic triphosphate
|
3'-Deoxydihydrostreptomycin 3'alpha,6-bisphosphate
| 2 |
replace
|
17,967 |
Amobarbitalをを化学構造で書くと?
|
C9H8ClN5S
|
C20H25NO6
|
C21H24N2O3
|
C31H23BrO2S
|
C11H18N2O3
| 4 |
formula
|
25,282 |
Nifurdazil (USAN/INN)をを組成式で表すと?
|
C11H13N3O3S. C4H11NO2
|
(C12H20O10)n
|
C28H34O8
|
C10H12N4O5
|
C22H27FN4O2
| 3 |
formula
|
9,175 |
(+)-Aphyllineをを化学式で表すと?
|
C6H15N2O6P
|
C24H31Cl2N5O7
|
C15H24N2O
|
C10H26N4
|
C49H71N13O10
| 2 |
formula
|
30,523 |
Endometriosisの別記述は?
|
腎細胞癌
|
子宮内膜症
|
Goldblatt 症候群 下位グループ 難聴と糖尿病を伴う歯牙軟骨形成不全症 (ODCD2)
|
RERE 関連神経発達症候群
|
びっくり病 下位グループ てんかんを伴う過剰驚愕症
| 1 |
replace
|
31,670 |
Vonapanitase (USAN/INN)の別名称は?
|
アナゾレンナトリウム
|
セファロチン
|
アルクロフェニン
|
ボナパニターゼ
|
赤ブドウ葉乾燥エキス混合物
| 3 |
replace
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.